Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1958 Jan;20(1):21–30. doi: 10.1136/hrt.20.1.21

THE EFFECTS OF ACUTE CARDIAC INFARCTION AND OF HEPARIN THERAPY ON THE LIPOPROTEINS

E M M Besterman 1
PMCID: PMC492783  PMID: 13499767

Full text

PDF
21

Images in this article

22Image
on p.22
24Image
on p.24
24Image
on p.24
25Image
on p.25
26Image
on p.26
26Image
on p.26
27Image
on p.27
28Image
on p.28
28Image
on p.28

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON N. G., FAWCETT B. An antichylomicronemic substance produced by heparin injection. Proc Soc Exp Biol Med. 1950 Aug;74(4):768–771. doi: 10.3181/00379727-74-18042. [DOI] [PubMed] [Google Scholar]
  2. Anfinsen C. B., Boyle E., Brown R. K. The Role of Heparin in Lipoprotein Metabolism. Science. 1952 May 30;115(2996):583–586. doi: 10.1126/science.115.2996.583. [DOI] [PubMed] [Google Scholar]
  3. BESTERMAN E. M., EVANS J. Antilipaemic agent without anticoagulant action. Br Med J. 1957 Feb 9;1(5014):310–312. doi: 10.1136/bmj.1.5014.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BESTERMAN E. M. Lipoproteins in coronary artery disease. Br Heart J. 1957 Oct;19(4):503–515. doi: 10.1136/hrt.19.4.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BOLINGER R. E., GRADY H. J., SLINKER B. J. The effect of injected heparin on the electrophoresis of the lipoproteins in patients with hypercholesterolemia. Am J Med Sci. 1954 Feb;227(2):193–200. doi: 10.1097/00000441-195402000-00012. [DOI] [PubMed] [Google Scholar]
  6. CAIRNS A., CONSTANTINIDES P. Mast cells in human atherosclerosis. Science. 1954 Jul 2;120(3105):31–32. doi: 10.1126/science.120.3105.31. [DOI] [PubMed] [Google Scholar]
  7. CONSTANTINIDES P., CAIRNS A., WERNER A. Antilipemic activity of sulfated polysaccharides. Arch Int Pharmacodyn Ther. 1954 Oct 1;99(3-4):334–345. [PubMed] [Google Scholar]
  8. DANGERFIELD W. G., SMITH E. B. An investigation of serum lipids and lipoproteins by paper electrophoresis. J Clin Pathol. 1955 May;8(2):132–139. doi: 10.1136/jcp.8.2.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. ENGELBERG H. Human endogenous lipemia clearing factor (active factor). Am J Physiol. 1955 May;181(2):309–312. doi: 10.1152/ajplegacy.1955.181.2.309. [DOI] [PubMed] [Google Scholar]
  10. GORDON R. S., Jr Interaction between oleate and the lipoproteins of human serum. J Clin Invest. 1955 Mar;34(3):477–484. doi: 10.1172/JCI103097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GRAHAM D. M., LYON T. P., GOFMAN J. W., JONES H. B., YANKLEY A., SIMONTON J., WHITE S. Blood lipids and human atherosclerosis. II. The influence of heparin upon lipoprotein metabolism. Circulation. 1951 Nov;4(5):666–673. doi: 10.1161/01.cir.4.5.666. [DOI] [PubMed] [Google Scholar]
  12. GROSSMAN M. I., MOELLER H. C., PALM L. Effect of lipemia and heparin on free fatty acid concentration of serum in humans. Proc Soc Exp Biol Med. 1955 Oct;90(1):106–109. doi: 10.3181/00379727-90-21953. [DOI] [PubMed] [Google Scholar]
  13. GRUNER A., HILDEN K., HILDEN T. The effect of heparin and protamine sulphate on the occurrence of chylomicrons in human blood. Scand J Clin Lab Invest. 1953;5(3):241–249. doi: 10.3109/00365515309094192. [DOI] [PubMed] [Google Scholar]
  14. HAVEL R. J., BOYLE E. Production of lipemia clearing factor during anaphylactoid shock. Proc Soc Exp Biol Med. 1954 Mar;85(3):468–472. doi: 10.3181/00379727-85-20921. [DOI] [PubMed] [Google Scholar]
  15. HERBST F. S., HURLEY N. A. Effects of heparin on alimentary hyperlipemia: an electrophoretic study. J Clin Invest. 1954 Jun;33(6):907–911. doi: 10.1172/JCI102964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. HERBST F. S., LEVER W. F., LYONS M. E., HURLEY N. A. Effects of heparin on the lipoproteins in hyperlipemia; electrophoretic study of the serum alpha and beta lipoproteins after their separation by fractionation of the plasma proteins or ultracentrifugal flotation. J Clin Invest. 1955 Apr;34(4):581–589. doi: 10.1172/JCI103106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. HERZSTEIN J., WANG C. I., ALDERSBERG D. Effect of heparin on plasma lipid partition in man: studies in normal persons and in patients with coronary atherosclerosis, nephrosis and primary hyperlipemia. Ann Intern Med. 1954 Feb;40(2):290–305. doi: 10.7326/0003-4819-40-2-290. [DOI] [PubMed] [Google Scholar]
  18. Hahn P. F. ABOLISHMENT OF ALIMENTARY LIPEMIA FOLLOWING INJECTION OF HEPARIN. Science. 1943 Jul 2;98(2531):19–20. doi: 10.1126/science.98.2531.19. [DOI] [PubMed] [Google Scholar]
  19. KORN E. D. Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J Biol Chem. 1955 Jul;215(1):1–14. [PubMed] [Google Scholar]
  20. ROSENBERG I. N. Serum lipids studied by electrophoresis on paper. Proc Soc Exp Biol Med. 1952 Aug-Sep;80(4):751–756. doi: 10.3181/00379727-80-19752. [DOI] [PubMed] [Google Scholar]
  21. ROSENBERG I. N. Serum lipids studied by electrophoresis on paper. Proc Soc Exp Biol Med. 1952 Aug-Sep;80(4):751–756. doi: 10.3181/00379727-80-19752. [DOI] [PubMed] [Google Scholar]
  22. SPITZER J. J. Properties of heparin-produced lipemia clearing factor. Am J Physiol. 1952 Nov;171(2):492–498. doi: 10.1152/ajplegacy.1952.171.2.492. [DOI] [PubMed] [Google Scholar]
  23. WORLEY L. M., LEQUIRE V. S. Lipemia clearing in peptone and anaphylactic shock. Proc Soc Exp Biol Med. 1955 Jun;89(2):181–183. doi: 10.3181/00379727-89-21750. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES